Elixirr said it achieved five record revenue months during the six-month period. Revenue in the first half of 2025 rose by 35% in total and by 17% on an organic basis compared to the comparable period ...

(Alliance News) - AstraZeneca PLC on Monday said a test of its baxdrostat drug showed a "meaningful reduction" in hypertension. The Cambridge, England-based pharmaceutical and biotechnology firm ...

The pound fell to USD1.3478 early Monday, from USD1.3503 at the time of the London equities close on Friday. The euro faded to USD1.1676 from USD1.1699. Against the yen, the dollar edged down to ...

"A regulatory decision by the FDA on this submission is expected in H1 2026. GSK is continuing to seek expanded indications for its RSV vaccine in other geographies including in the European Economic ...

(Alliance News) - South32 Ltd said on Monday it expects to book an impairment charge of its Mozal aluminium smelter in Mozambique due to uncertainty over electricity supply. The Perth-based ...

(Alliance News) - DCC announced a deal to sell a part of its technology arm for GBP100 million, GSK is pursuing US approval for expanded use of its RSV jab, while South32 warned of an impairment at an ...